Blockade of CTLA-4 and PD-1 binding through antibodies alone has led to highly significant clinical responses, and combining these antibodies with a vaccine might strengthen the antitumor effects of either alone.
1
—
—
Blockade of CTLA-4 and PD-1 binding through antibodies alone has led to highly significant clinical responses, and combining these antibodies with a vaccine might strengthen the antitumor effects of either alone.